PubMed=3857588; DOI=10.1073/pnas.82.8.2394; PMCID=PMC397564
Stampfer M.R., Bartley J.C.
Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene.
Proc. Natl. Acad. Sci. U.S.A. 82:2394-2398(1985)

Patent=US4808532
Stampfer M.R.
Continuous human cell lines and method of making same.
Patent number US4808532, 28-Feb-1989

PubMed=2702624; DOI=10.1016/0165-4608(89)90056-3
Walen K.H., Stampfer M.R.
Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality.
Cancer Genet. Cytogenet. 37:249-261(1989)

DOI=10.1007/978-1-4612-0411-4_10
Yang T.C., Stampfer M.R., Rhim J.S.
Neoplastic transformation of human epithelial cells by ionizing radiation.
(In book chapter) Neoplastic transformation in human cell system. Mechanism of carcinogenesis; Rhim J.S., Dritschilo A. (eds.); pp.103-111; Humana Press; New York; USA (1990)

DOI=10.1007/978-1-4612-0411-4_26
Stampfer M.R., Yaswen P., Parry G., Hosoda J.
An in vitro human mammary epithelial model system for studies of differentiation and carcinogenesis.
(In book chapter) Neoplastic transformation in human cell system. Mechanism of carcinogenesis; Rhim J.S., Dritschilo A. (eds.); pp.259-267; Humana Press; New York; USA (1990)

PubMed=8504475; DOI=10.1093/carcin/14.5.833
Lehman T.A., Modali R.V., Boukamp P., Stanek J., Bennett W.P., Welsh J.A., Metcalf R.A., Stampfer M.R., Fusenig N.E., Rogan E.M., Harris C.C.
p53 mutations in human immortalized epithelial cell lines.
Carcinogenesis 14:833-839(1993)

PubMed=9303071; DOI=10.1002/(SICI)1520-6823(1997)5:3<134::AID-ROI10>3.0.CO;2-6
Yang T.C.-H., Georgy K.A., Craise L.M., Durante M.
Initiation of oncogenic transformation in human mammary epithelial cells by charged particles.
Radiat. Oncol. Investig. 5:134-138(1997)

PubMed=9398663; DOI=10.1091/mbc.8.12.2391; PMCID=PMC25715
Stampfer M.R., Bodnar A.G., Garbe J.C., Wong M., Pan A., Villeponteau B., Yaswen P.
Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells.
Mol. Biol. Cell 8:2391-2405(1997)

PubMed=9671407; DOI=10.1038/sj.onc.1201814
Sweeney K.J., Swarbrick A., Sutherland R.L., Musgrove E.A.
Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
Oncogene 16:2865-2878(1998)

PubMed=24176112; DOI=10.1186/gb-2013-14-10-r110; PMCID=PMC3937590
Daemen A., Griffith O.L., Heiser L.M., Wang N.J., Enache O.M., Sanborn Z., Pepin F., Durinck S., Korkola J.E., Griffith M., Hur J.S., Huh N., Chung J., Cope L., Fackler M.J., Umbricht C.B., Sukumar S., Seth P., Sukhatme V.P., Jakkula L.R., Lu Y.-L., Mills G.B., Cho R.J., Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.
Modeling precision treatment of breast cancer.
Genome Biol. 14:R110.1-R110.14(2013)

PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981
Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:e954893.1-e954893.12(2014)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

PubMed=28889351; DOI=10.1007/s10549-017-4496-x
Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L., Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E., Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J., Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E., Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F., Lakhani S.R.
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Breast Cancer Res. Treat. 167:289-301(2018)